Format

Send to

Choose Destination
Hum Genet. 2019 Mar;138(3):287-289. doi: 10.1007/s00439-019-01984-z. Epub 2019 Feb 27.

A response to "Personalised medicine and population health: breast and ovarian cancer".

Author information

1
University of Cambridge, Cambridge, UK.
2
University of California, Irvine, USA.
3
University of California, Davis, USA.
4
Radboud University Medical Center, Nijmegen, Netherlands.
5
University of Toronto, Toronto, Canada.
6
Université Laval, Quebec City, Canada.
7
Queen Mary University of London, London, UK.
8
Institut Gustave Roussy, Villejuif, France.
9
Leiden University, Leiden, Netherlands.
10
Sunnybrook Health Sciences Centre, Toronto, Canada.
11
Karolinska Institute, Stockholm, Sweden.
12
University of California, San Francisco, USA. Laura.Esserman@ucsf.edu.
13
National Cancer Institute, Bethesda, USA.
14
University of Utah, Salt Lake City, USA.
15
McGill University, Montreal, Canada.
16
Harvard University, Cambridge, USA.
17
University of California, San Diego, USA.
18
Sunnybrook Research Institute, Toronto, Canada.
19
University of Chicago, Chicago, USA.
20
University College London, London, UK.
21
Netherlands Cancer Institute, Amsterdam, The Netherlands.
22
University of California, San Francisco, USA.
23
University of California, Los Angeles, USA.
24
University of Ottawa, Ottawa, Canada.
PMID:
30810870
DOI:
10.1007/s00439-019-01984-z
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Springer Icon for eScholarship, California Digital Library, University of California
Loading ...
Support Center